Metropolis Healthcare Limited (NSE:METROPOLIS)
India · Delayed Price · Currency is INR 575.00
+6.30 (1.11%)
Nov 4, 2026, 3:30 PM IST
Metropolis Healthcare Market Cap
Metropolis Healthcare has a market cap or net worth of 119.29 billion as of November 4, 2026. It is the 8,735th most valuable company in the world and the 536th biggest in India. Its market cap has increased by 14.83% in one year.
Market Cap
119.29B
Enterprise Value
118.61B
Revenue
17.83B
Global Rank
Country Rank
#536 India
PE Ratio
53.08
ChartMarket Cap Chart
Since April 15, 2019, Metropolis Healthcare's market cap has increased from 48.16B to 119.29B, an increase of 147.67%. That is a compound annual growth rate of 12.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 120.58B | 20.63% |
| Dec 31, 2025 | 99.96B | -6.11% |
| Dec 31, 2024 | 106.46B | 23.85% |
| Dec 29, 2023 | 85.96B | 26.46% |
| Dec 30, 2022 | 67.98B | -61.39% |
| Dec 31, 2021 | 176.07B | 75.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.25T |
| Divi's Laboratories | 2.67T |
| Laurus Labs | 1.26T |
| Zydus Lifesciences | 1.24T |
| Marksans Pharma | 142.88B |
| CORONA Remedies | 138.93B |
| Concord Biotech | 129.10B |
| Rainbow Children's Medicare | 126.86B |